Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,200
Closed -$1.62M 129
2022
Q3
$1.62M Sell
7,200
-5,300
-42% -$1.28M 0.06% 409
2022
Q2
$3.04M Sell
12,500
-15,900
-56% -$3.9M 0.11% 238
2022
Q1
$6.87M Buy
28,400
+10,400
+58% +$2.39M 0.24% 70
2021
Q4
$4.05M Sell
18,000
-6,700
-27% -$1.41M 0.14% 150
2021
Q3
$5.25M Buy
24,700
+4,800
+24% +$1.1M 0.17% 118
2021
Q2
$4.85M Buy
19,900
+11,200
+129% +$2.76M 0.16% 126
2021
Q1
$2.17M Sell
8,700
-9,800
-53% -$2.34M 0.07% 370
2020
Q4
$4.25M Buy
+18,500
New +$4.27M 0.19% 100

Other funds holding AMGN

Point72 Hong Kong's AMGN Position: Q1 2024 in Review

Point72 Hong Kong sold out of Amgen (AMGN) in Q1 2024, closing a stake of 8,404 shares — an estimated $2.42M sold.

Point72 Hong Kong first reported a position in AMGN in Q4 2014 and held it in 18 quarters. The position peaked at $7.79M in Q2 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Point72 Hong Kong reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 8,404 Amgen shares in Q1 2024, an estimated $2.42M.
  • Point72 Hong Kong first reported a position in Amgen in Q4 2014 and held it in 18 quarters.
  • Point72 Hong Kong's Amgen position peaked at $7.79M in Q2 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.